nodes	percent_of_prediction	percent_of_DWPC	metapath
Acenocoumarol—ALB—hematologic cancer	0.138	1	CbGaD
Acenocoumarol—ORM1—Imatinib—hematologic cancer	0.0451	0.0721	CbGbCtD
Acenocoumarol—CYP1A2—Anagrelide—hematologic cancer	0.0365	0.0583	CbGbCtD
Acenocoumarol—CYP2C9—Bexarotene—hematologic cancer	0.0228	0.0364	CbGbCtD
Acenocoumarol—CYP1A2—Carmustine—hematologic cancer	0.0192	0.0306	CbGbCtD
Acenocoumarol—ALB—Imatinib—hematologic cancer	0.019	0.0303	CbGbCtD
Acenocoumarol—CYP2C9—Idarubicin—hematologic cancer	0.0189	0.0302	CbGbCtD
Acenocoumarol—CYP2C19—Bortezomib—hematologic cancer	0.0168	0.0269	CbGbCtD
Acenocoumarol—CYP1A2—Methoxsalen—hematologic cancer	0.0163	0.0261	CbGbCtD
Acenocoumarol—CYP1A2—Bortezomib—hematologic cancer	0.0155	0.0248	CbGbCtD
Acenocoumarol—CYP1A2—Daunorubicin—hematologic cancer	0.0148	0.0237	CbGbCtD
Acenocoumarol—CYP2C19—Thalidomide—hematologic cancer	0.0146	0.0234	CbGbCtD
Acenocoumarol—CYP1A2—Alitretinoin—hematologic cancer	0.0145	0.0232	CbGbCtD
Acenocoumarol—CYP2C9—Bortezomib—hematologic cancer	0.014	0.0223	CbGbCtD
Acenocoumarol—CYP2C19—Teniposide—hematologic cancer	0.014	0.0223	CbGbCtD
Acenocoumarol—CYP1A2—Thalidomide—hematologic cancer	0.0135	0.0216	CbGbCtD
Acenocoumarol—CYP3A4—Bexarotene—hematologic cancer	0.0133	0.0212	CbGbCtD
Acenocoumarol—CYP2C19—Ifosfamide—hematologic cancer	0.0129	0.0206	CbGbCtD
Acenocoumarol—ALB—Prednisone—hematologic cancer	0.0125	0.02	CbGbCtD
Acenocoumarol—CYP3A4—Lomustine—hematologic cancer	0.0123	0.0197	CbGbCtD
Acenocoumarol—CYP3A4—Busulfan—hematologic cancer	0.0123	0.0197	CbGbCtD
Acenocoumarol—CYP2C19—Imatinib—hematologic cancer	0.0123	0.0197	CbGbCtD
Acenocoumarol—CYP2C9—Thalidomide—hematologic cancer	0.0122	0.0194	CbGbCtD
Acenocoumarol—ALB—Irinotecan—hematologic cancer	0.0119	0.019	CbGbCtD
Acenocoumarol—CYP1A2—Dacarbazine—hematologic cancer	0.0116	0.0186	CbGbCtD
Acenocoumarol—CYP2C9—Teniposide—hematologic cancer	0.0116	0.0186	CbGbCtD
Acenocoumarol—CYP1A2—Imatinib—hematologic cancer	0.0114	0.0182	CbGbCtD
Acenocoumarol—CYP3A4—Thiotepa—hematologic cancer	0.011	0.0175	CbGbCtD
Acenocoumarol—CYP2C9—Ifosfamide—hematologic cancer	0.0107	0.0171	CbGbCtD
Acenocoumarol—CYP2C9—Imatinib—hematologic cancer	0.0102	0.0164	CbGbCtD
Acenocoumarol—CYP2C9—Nilotinib—hematologic cancer	0.0093	0.0149	CbGbCtD
Acenocoumarol—CYP1A2—Dasatinib—hematologic cancer	0.00913	0.0146	CbGbCtD
Acenocoumarol—CYP3A4—Methoxsalen—hematologic cancer	0.00854	0.0136	CbGbCtD
Acenocoumarol—CYP3A4—Bortezomib—hematologic cancer	0.00813	0.013	CbGbCtD
Acenocoumarol—CYP2C19—Prednisone—hematologic cancer	0.00811	0.013	CbGbCtD
Acenocoumarol—CYP3A4—Daunorubicin—hematologic cancer	0.00777	0.0124	CbGbCtD
Acenocoumarol—CYP3A4—Cytarabine—hematologic cancer	0.00686	0.011	CbGbCtD
Acenocoumarol—CYP3A4—Teniposide—hematologic cancer	0.00675	0.0108	CbGbCtD
Acenocoumarol—ALB—Methotrexate—hematologic cancer	0.00628	0.01	CbGbCtD
Acenocoumarol—CYP3A4—Ifosfamide—hematologic cancer	0.00623	0.00996	CbGbCtD
Acenocoumarol—CYP3A4—Imatinib—hematologic cancer	0.00595	0.00951	CbGbCtD
Acenocoumarol—CYP1A2—Etoposide—hematologic cancer	0.00568	0.00908	CbGbCtD
Acenocoumarol—CYP3A4—Ruxolitinib—hematologic cancer	0.00561	0.00896	CbGbCtD
Acenocoumarol—CYP3A4—Nilotinib—hematologic cancer	0.00541	0.00864	CbGbCtD
Acenocoumarol—CYP3A4—Vinorelbine—hematologic cancer	0.00536	0.00857	CbGbCtD
Acenocoumarol—CYP2C9—Cisplatin—hematologic cancer	0.00521	0.00833	CbGbCtD
Acenocoumarol—CYP2C19—Dexamethasone—hematologic cancer	0.00507	0.00809	CbGbCtD
Acenocoumarol—CYP3A4—Triamcinolone—hematologic cancer	0.00491	0.00784	CbGbCtD
Acenocoumarol—CYP3A4—Dasatinib—hematologic cancer	0.00478	0.00764	CbGbCtD
Acenocoumarol—CYP3A4—Mitoxantrone—hematologic cancer	0.00472	0.00755	CbGbCtD
Acenocoumarol—CYP2C9—Dexamethasone—hematologic cancer	0.00421	0.00673	CbGbCtD
Acenocoumarol—CYP3A4—Betamethasone—hematologic cancer	0.00421	0.00673	CbGbCtD
Acenocoumarol—CYP3A4—Prednisolone—hematologic cancer	0.00415	0.00664	CbGbCtD
Acenocoumarol—CYP3A4—Prednisone—hematologic cancer	0.00392	0.00627	CbGbCtD
Acenocoumarol—CYP3A4—Irinotecan—hematologic cancer	0.00372	0.00594	CbGbCtD
Acenocoumarol—CYP3A4—Vinblastine—hematologic cancer	0.00331	0.00528	CbGbCtD
Acenocoumarol—CYP3A4—Vincristine—hematologic cancer	0.00325	0.00519	CbGbCtD
Acenocoumarol—CYP3A4—Etoposide—hematologic cancer	0.00298	0.00476	CbGbCtD
Acenocoumarol—CYP3A4—Dexamethasone—hematologic cancer	0.00245	0.00391	CbGbCtD
Acenocoumarol—CYP3A4—Doxorubicin—hematologic cancer	0.00203	0.00325	CbGbCtD
Acenocoumarol—Dicoumarol—NQO1—hematologic cancer	0.00198	0.689	CrCbGaD
Acenocoumarol—VKORC1—gonad—hematologic cancer	0.00157	0.113	CbGeAlD
Acenocoumarol—VKORC1—lung—hematologic cancer	0.0012	0.0865	CbGeAlD
Acenocoumarol—VKORC1—testis—hematologic cancer	0.00113	0.0817	CbGeAlD
Acenocoumarol—ORM1—hematopoietic system—hematologic cancer	0.00111	0.0806	CbGeAlD
Acenocoumarol—VKORC1—lymph node—hematologic cancer	0.000819	0.0592	CbGeAlD
Acenocoumarol—CYP2C19—hematopoietic system—hematologic cancer	0.000787	0.0569	CbGeAlD
Acenocoumarol—ORM1—blood—hematologic cancer	0.000738	0.0534	CbGeAlD
Acenocoumarol—ORM1—bone marrow—hematologic cancer	0.000715	0.0517	CbGeAlD
Acenocoumarol—ORM1—lung—hematologic cancer	0.000647	0.0468	CbGeAlD
Acenocoumarol—CYP1A2—hematopoietic system—hematologic cancer	0.000643	0.0465	CbGeAlD
Acenocoumarol—CYP2C9—hematopoietic system—hematologic cancer	0.00061	0.0441	CbGeAlD
Acenocoumarol—ALB—testis—hematologic cancer	0.000536	0.0387	CbGeAlD
Acenocoumarol—CYP2C19—blood—hematologic cancer	0.000521	0.0377	CbGeAlD
Acenocoumarol—CYP3A4—hematopoietic system—hematologic cancer	0.000465	0.0336	CbGeAlD
Acenocoumarol—Flunitrazepam—UGT1A1—hematologic cancer	0.000464	0.162	CrCbGaD
Acenocoumarol—ORM1—lymph node—hematologic cancer	0.000443	0.032	CbGeAlD
Acenocoumarol—CYP1A2—blood—hematologic cancer	0.000426	0.0308	CbGeAlD
Acenocoumarol—CYP2C9—blood—hematologic cancer	0.000404	0.0292	CbGeAlD
Acenocoumarol—ALB—lymph node—hematologic cancer	0.000388	0.0281	CbGeAlD
Acenocoumarol—CYP1A2—lung—hematologic cancer	0.000373	0.027	CbGeAlD
Acenocoumarol—CYP3A4—blood—hematologic cancer	0.000308	0.0223	CbGeAlD
Acenocoumarol—Phenprocoumon—ALB—hematologic cancer	0.000176	0.0613	CrCbGaD
Acenocoumarol—Dermatitis—Procarbazine—hematologic cancer	0.000171	0.00092	CcSEcCtD
Acenocoumarol—Decreased appetite—Bortezomib—hematologic cancer	0.00017	0.000917	CcSEcCtD
Acenocoumarol—Hypersensitivity—Vinblastine—hematologic cancer	0.000169	0.000913	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Bortezomib—hematologic cancer	0.000169	0.000911	CcSEcCtD
Acenocoumarol—Urticaria—Lenalidomide—hematologic cancer	0.000169	0.000911	CcSEcCtD
Acenocoumarol—Vomiting—Dasatinib—hematologic cancer	0.000169	0.00091	CcSEcCtD
Acenocoumarol—Vomiting—Bexarotene—hematologic cancer	0.000169	0.00091	CcSEcCtD
Acenocoumarol—Decreased appetite—Bleomycin—hematologic cancer	0.000169	0.00091	CcSEcCtD
Acenocoumarol—Vomiting—Fludarabine—hematologic cancer	0.000168	0.000908	CcSEcCtD
Acenocoumarol—Haemoglobin—Triamcinolone—hematologic cancer	0.000168	0.000907	CcSEcCtD
Acenocoumarol—Body temperature increased—Lenalidomide—hematologic cancer	0.000168	0.000906	CcSEcCtD
Acenocoumarol—Diarrhoea—Nilotinib—hematologic cancer	0.000168	0.000905	CcSEcCtD
Acenocoumarol—Haemorrhage—Triamcinolone—hematologic cancer	0.000167	0.000902	CcSEcCtD
Acenocoumarol—Dermatitis—Dasatinib—hematologic cancer	0.000167	0.000902	CcSEcCtD
Acenocoumarol—Dermatitis—Bexarotene—hematologic cancer	0.000167	0.000902	CcSEcCtD
Acenocoumarol—Diarrhoea—Imatinib—hematologic cancer	0.000167	0.0009	CcSEcCtD
Acenocoumarol—Dermatitis—Fludarabine—hematologic cancer	0.000167	0.000899	CcSEcCtD
Acenocoumarol—Decreased appetite—Vinorelbine—hematologic cancer	0.000166	0.000895	CcSEcCtD
Acenocoumarol—Nausea—Busulfan—hematologic cancer	0.000166	0.000894	CcSEcCtD
Acenocoumarol—Body temperature increased—Hydroxyurea—hematologic cancer	0.000166	0.000894	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Vinorelbine—hematologic cancer	0.000165	0.000889	CcSEcCtD
Acenocoumarol—Diarrhoea—Cladribine—hematologic cancer	0.000164	0.000884	CcSEcCtD
Acenocoumarol—Alopecia—Etoposide—hematologic cancer	0.000163	0.000879	CcSEcCtD
Acenocoumarol—Hypersensitivity—Melphalan—hematologic cancer	0.000161	0.000869	CcSEcCtD
Acenocoumarol—Nausea—Procarbazine—hematologic cancer	0.000161	0.000868	CcSEcCtD
Acenocoumarol—Vomiting—Chlorambucil—hematologic cancer	0.000159	0.00086	CcSEcCtD
Acenocoumarol—Decreased appetite—Thiotepa—hematologic cancer	0.000159	0.000855	CcSEcCtD
Acenocoumarol—Nausea—Bexarotene—hematologic cancer	0.000158	0.00085	CcSEcCtD
Acenocoumarol—Nausea—Dasatinib—hematologic cancer	0.000158	0.00085	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Thiotepa—hematologic cancer	0.000157	0.000849	CcSEcCtD
Acenocoumarol—Nausea—Fludarabine—hematologic cancer	0.000157	0.000848	CcSEcCtD
Acenocoumarol—Diarrhoea—Vinblastine—hematologic cancer	0.000157	0.000848	CcSEcCtD
Acenocoumarol—Hypersensitivity—Lenalidomide—hematologic cancer	0.000157	0.000845	CcSEcCtD
Acenocoumarol—Warfarin—ALB—hematologic cancer	0.000156	0.0543	CrCbGaD
Acenocoumarol—Vomiting—Nilotinib—hematologic cancer	0.000156	0.000841	CcSEcCtD
Acenocoumarol—Urticaria—Bortezomib—hematologic cancer	0.000155	0.000838	CcSEcCtD
Acenocoumarol—Vomiting—Imatinib—hematologic cancer	0.000155	0.000836	CcSEcCtD
Acenocoumarol—Body temperature increased—Bortezomib—hematologic cancer	0.000155	0.000834	CcSEcCtD
Acenocoumarol—Dermatitis—Nilotinib—hematologic cancer	0.000155	0.000833	CcSEcCtD
Acenocoumarol—Hypersensitivity—Hydroxyurea—hematologic cancer	0.000154	0.000833	CcSEcCtD
Acenocoumarol—Urticaria—Bleomycin—hematologic cancer	0.000154	0.000832	CcSEcCtD
Acenocoumarol—Dermatitis—Imatinib—hematologic cancer	0.000154	0.000829	CcSEcCtD
Acenocoumarol—Body temperature increased—Bleomycin—hematologic cancer	0.000153	0.000828	CcSEcCtD
Acenocoumarol—Decreased appetite—Thalidomide—hematologic cancer	0.000153	0.000827	CcSEcCtD
Acenocoumarol—Haemoglobin—Betamethasone—hematologic cancer	0.000153	0.000823	CcSEcCtD
Acenocoumarol—Haemoglobin—Dexamethasone—hematologic cancer	0.000153	0.000823	CcSEcCtD
Acenocoumarol—Vomiting—Cladribine—hematologic cancer	0.000152	0.000822	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Thalidomide—hematologic cancer	0.000152	0.000821	CcSEcCtD
Acenocoumarol—Haemorrhage—Betamethasone—hematologic cancer	0.000152	0.000819	CcSEcCtD
Acenocoumarol—Haemorrhage—Dexamethasone—hematologic cancer	0.000152	0.000819	CcSEcCtD
Acenocoumarol—Urticaria—Vinorelbine—hematologic cancer	0.000152	0.000818	CcSEcCtD
Acenocoumarol—Body temperature increased—Vinorelbine—hematologic cancer	0.000151	0.000814	CcSEcCtD
Acenocoumarol—Dermatitis—Cladribine—hematologic cancer	0.000151	0.000814	CcSEcCtD
Acenocoumarol—Diarrhoea—Melphalan—hematologic cancer	0.00015	0.000807	CcSEcCtD
Acenocoumarol—Nausea—Chlorambucil—hematologic cancer	0.000149	0.000803	CcSEcCtD
Acenocoumarol—Decreased appetite—Carmustine—hematologic cancer	0.000147	0.000794	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Carmustine—hematologic cancer	0.000146	0.000789	CcSEcCtD
Acenocoumarol—Vomiting—Vinblastine—hematologic cancer	0.000146	0.000788	CcSEcCtD
Acenocoumarol—Decreased appetite—Alitretinoin—hematologic cancer	0.000146	0.000787	CcSEcCtD
Acenocoumarol—Nausea—Nilotinib—hematologic cancer	0.000146	0.000786	CcSEcCtD
Acenocoumarol—Diarrhoea—Lenalidomide—hematologic cancer	0.000145	0.000784	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Alitretinoin—hematologic cancer	0.000145	0.000782	CcSEcCtD
Acenocoumarol—Urticaria—Thiotepa—hematologic cancer	0.000145	0.000781	CcSEcCtD
Acenocoumarol—Nausea—Imatinib—hematologic cancer	0.000145	0.000781	CcSEcCtD
Acenocoumarol—Decreased appetite—Ifosfamide—hematologic cancer	0.000144	0.000778	CcSEcCtD
Acenocoumarol—Body temperature increased—Thiotepa—hematologic cancer	0.000144	0.000778	CcSEcCtD
Acenocoumarol—Hypersensitivity—Bortezomib—hematologic cancer	0.000144	0.000777	CcSEcCtD
Acenocoumarol—Diarrhoea—Hydroxyurea—hematologic cancer	0.000143	0.000773	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Ifosfamide—hematologic cancer	0.000143	0.000772	CcSEcCtD
Acenocoumarol—Hypersensitivity—Bleomycin—hematologic cancer	0.000143	0.000771	CcSEcCtD
Acenocoumarol—Nausea—Cladribine—hematologic cancer	0.000142	0.000768	CcSEcCtD
Acenocoumarol—Hypersensitivity—Vinorelbine—hematologic cancer	0.000141	0.000759	CcSEcCtD
Acenocoumarol—Decreased appetite—Vincristine—hematologic cancer	0.000141	0.000758	CcSEcCtD
Acenocoumarol—Urticaria—Thalidomide—hematologic cancer	0.00014	0.000756	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Vincristine—hematologic cancer	0.00014	0.000753	CcSEcCtD
Acenocoumarol—Body temperature increased—Thalidomide—hematologic cancer	0.000139	0.000752	CcSEcCtD
Acenocoumarol—Vomiting—Melphalan—hematologic cancer	0.000139	0.00075	CcSEcCtD
Acenocoumarol—Dermatitis—Melphalan—hematologic cancer	0.000138	0.000743	CcSEcCtD
Acenocoumarol—Decreased appetite—Irinotecan—hematologic cancer	0.000137	0.000738	CcSEcCtD
Acenocoumarol—Decreased appetite—Mitoxantrone—hematologic cancer	0.000137	0.000738	CcSEcCtD
Acenocoumarol—Nausea—Vinblastine—hematologic cancer	0.000137	0.000736	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Irinotecan—hematologic cancer	0.000136	0.000733	CcSEcCtD
Acenocoumarol—Vomiting—Lenalidomide—hematologic cancer	0.000135	0.000729	CcSEcCtD
Acenocoumarol—Hypersensitivity—Thiotepa—hematologic cancer	0.000134	0.000725	CcSEcCtD
Acenocoumarol—Alopecia—Dexamethasone—hematologic cancer	0.000134	0.000723	CcSEcCtD
Acenocoumarol—Alopecia—Betamethasone—hematologic cancer	0.000134	0.000723	CcSEcCtD
Acenocoumarol—Body temperature increased—Carmustine—hematologic cancer	0.000134	0.000722	CcSEcCtD
Acenocoumarol—Dermatitis—Lenalidomide—hematologic cancer	0.000134	0.000722	CcSEcCtD
Acenocoumarol—Diarrhoea—Bortezomib—hematologic cancer	0.000134	0.000722	CcSEcCtD
Acenocoumarol—Decreased appetite—Gemcitabine—hematologic cancer	0.000133	0.000719	CcSEcCtD
Acenocoumarol—Urticaria—Alitretinoin—hematologic cancer	0.000133	0.000719	CcSEcCtD
Acenocoumarol—Vomiting—Hydroxyurea—hematologic cancer	0.000133	0.000719	CcSEcCtD
Acenocoumarol—Haemoglobin—Prednisone—hematologic cancer	0.000133	0.000716	CcSEcCtD
Acenocoumarol—Body temperature increased—Alitretinoin—hematologic cancer	0.000133	0.000716	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Gemcitabine—hematologic cancer	0.000132	0.000714	CcSEcCtD
Acenocoumarol—Haemorrhage—Prednisone—hematologic cancer	0.000132	0.000713	CcSEcCtD
Acenocoumarol—Dermatitis—Hydroxyurea—hematologic cancer	0.000132	0.000712	CcSEcCtD
Acenocoumarol—Urticaria—Ifosfamide—hematologic cancer	0.000132	0.000711	CcSEcCtD
Acenocoumarol—Body temperature increased—Ifosfamide—hematologic cancer	0.000131	0.000707	CcSEcCtD
Acenocoumarol—Diarrhoea—Vinorelbine—hematologic cancer	0.000131	0.000705	CcSEcCtD
Acenocoumarol—Hypersensitivity—Thalidomide—hematologic cancer	0.00013	0.000701	CcSEcCtD
Acenocoumarol—Nausea—Melphalan—hematologic cancer	0.00013	0.0007	CcSEcCtD
Acenocoumarol—Body temperature increased—Vincristine—hematologic cancer	0.000128	0.00069	CcSEcCtD
Acenocoumarol—Nausea—Lenalidomide—hematologic cancer	0.000126	0.000681	CcSEcCtD
Acenocoumarol—Urticaria—Mitoxantrone—hematologic cancer	0.000125	0.000675	CcSEcCtD
Acenocoumarol—Hypersensitivity—Carmustine—hematologic cancer	0.000125	0.000673	CcSEcCtD
Acenocoumarol—Diarrhoea—Thiotepa—hematologic cancer	0.000125	0.000673	CcSEcCtD
Acenocoumarol—Body temperature increased—Irinotecan—hematologic cancer	0.000125	0.000672	CcSEcCtD
Acenocoumarol—Body temperature increased—Mitoxantrone—hematologic cancer	0.000125	0.000672	CcSEcCtD
Acenocoumarol—Nausea—Hydroxyurea—hematologic cancer	0.000125	0.000671	CcSEcCtD
Acenocoumarol—Vomiting—Bortezomib—hematologic cancer	0.000124	0.000671	CcSEcCtD
Acenocoumarol—Decreased appetite—Cisplatin—hematologic cancer	0.000124	0.000671	CcSEcCtD
Acenocoumarol—Hypersensitivity—Alitretinoin—hematologic cancer	0.000124	0.000667	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Cisplatin—hematologic cancer	0.000123	0.000666	CcSEcCtD
Acenocoumarol—Vomiting—Bleomycin—hematologic cancer	0.000123	0.000666	CcSEcCtD
Acenocoumarol—Dermatitis—Bortezomib—hematologic cancer	0.000123	0.000665	CcSEcCtD
Acenocoumarol—Dermatitis—Bleomycin—hematologic cancer	0.000122	0.000659	CcSEcCtD
Acenocoumarol—Hypersensitivity—Ifosfamide—hematologic cancer	0.000122	0.000659	CcSEcCtD
Acenocoumarol—Vomiting—Vinorelbine—hematologic cancer	0.000121	0.000655	CcSEcCtD
Acenocoumarol—Body temperature increased—Gemcitabine—hematologic cancer	0.000121	0.000654	CcSEcCtD
Acenocoumarol—Diarrhoea—Thalidomide—hematologic cancer	0.000121	0.000651	CcSEcCtD
Acenocoumarol—Dermatitis—Vinorelbine—hematologic cancer	0.00012	0.000649	CcSEcCtD
Acenocoumarol—Hypersensitivity—Vincristine—hematologic cancer	0.000119	0.000643	CcSEcCtD
Acenocoumarol—Haematuria—Methotrexate—hematologic cancer	0.000117	0.000633	CcSEcCtD
Acenocoumarol—Alopecia—Prednisone—hematologic cancer	0.000117	0.00063	CcSEcCtD
Acenocoumarol—Nausea—Bortezomib—hematologic cancer	0.000116	0.000627	CcSEcCtD
Acenocoumarol—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000116	0.000626	CcSEcCtD
Acenocoumarol—Hypersensitivity—Irinotecan—hematologic cancer	0.000116	0.000626	CcSEcCtD
Acenocoumarol—Vomiting—Thiotepa—hematologic cancer	0.000116	0.000625	CcSEcCtD
Acenocoumarol—Diarrhoea—Carmustine—hematologic cancer	0.000116	0.000625	CcSEcCtD
Acenocoumarol—Nausea—Bleomycin—hematologic cancer	0.000115	0.000622	CcSEcCtD
Acenocoumarol—Dermatitis—Thiotepa—hematologic cancer	0.000115	0.00062	CcSEcCtD
Acenocoumarol—Diarrhoea—Alitretinoin—hematologic cancer	0.000115	0.000619	CcSEcCtD
Acenocoumarol—Decreased appetite—Etoposide—hematologic cancer	0.000114	0.000614	CcSEcCtD
Acenocoumarol—Diarrhoea—Ifosfamide—hematologic cancer	0.000114	0.000612	CcSEcCtD
Acenocoumarol—Nausea—Vinorelbine—hematologic cancer	0.000113	0.000612	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Etoposide—hematologic cancer	0.000113	0.00061	CcSEcCtD
Acenocoumarol—Body temperature increased—Cisplatin—hematologic cancer	0.000113	0.00061	CcSEcCtD
Acenocoumarol—Vomiting—Thalidomide—hematologic cancer	0.000112	0.000605	CcSEcCtD
Acenocoumarol—Dermatitis—Thalidomide—hematologic cancer	0.000111	0.000599	CcSEcCtD
Acenocoumarol—Haemoglobin—Methotrexate—hematologic cancer	0.000111	0.000599	CcSEcCtD
Acenocoumarol—Diarrhoea—Vincristine—hematologic cancer	0.000111	0.000597	CcSEcCtD
Acenocoumarol—Haemorrhage—Methotrexate—hematologic cancer	0.00011	0.000596	CcSEcCtD
Acenocoumarol—Haematuria—Epirubicin—hematologic cancer	0.00011	0.000592	CcSEcCtD
Acenocoumarol—Nausea—Thiotepa—hematologic cancer	0.000108	0.000584	CcSEcCtD
Acenocoumarol—Diarrhoea—Irinotecan—hematologic cancer	0.000108	0.000581	CcSEcCtD
Acenocoumarol—Diarrhoea—Mitoxantrone—hematologic cancer	0.000108	0.000581	CcSEcCtD
Acenocoumarol—Vomiting—Carmustine—hematologic cancer	0.000108	0.000581	CcSEcCtD
Acenocoumarol—Dermatitis—Carmustine—hematologic cancer	0.000107	0.000576	CcSEcCtD
Acenocoumarol—Vomiting—Alitretinoin—hematologic cancer	0.000107	0.000576	CcSEcCtD
Acenocoumarol—Dermatitis—Alitretinoin—hematologic cancer	0.000106	0.00057	CcSEcCtD
Acenocoumarol—Vomiting—Ifosfamide—hematologic cancer	0.000105	0.000569	CcSEcCtD
Acenocoumarol—Hypersensitivity—Cisplatin—hematologic cancer	0.000105	0.000568	CcSEcCtD
Acenocoumarol—Diarrhoea—Gemcitabine—hematologic cancer	0.000105	0.000566	CcSEcCtD
Acenocoumarol—Nausea—Thalidomide—hematologic cancer	0.000105	0.000565	CcSEcCtD
Acenocoumarol—Dermatitis—Ifosfamide—hematologic cancer	0.000105	0.000564	CcSEcCtD
Acenocoumarol—Urticaria—Etoposide—hematologic cancer	0.000104	0.000561	CcSEcCtD
Acenocoumarol—Haemoglobin—Epirubicin—hematologic cancer	0.000104	0.00056	CcSEcCtD
Acenocoumarol—Body temperature increased—Etoposide—hematologic cancer	0.000104	0.000559	CcSEcCtD
Acenocoumarol—Haemorrhage—Epirubicin—hematologic cancer	0.000103	0.000558	CcSEcCtD
Acenocoumarol—Vomiting—Vincristine—hematologic cancer	0.000103	0.000555	CcSEcCtD
Acenocoumarol—Urticaria—Prednisolone—hematologic cancer	0.000103	0.000554	CcSEcCtD
Acenocoumarol—Dermatitis—Vincristine—hematologic cancer	0.000102	0.00055	CcSEcCtD
Acenocoumarol—Haematuria—Doxorubicin—hematologic cancer	0.000102	0.000548	CcSEcCtD
Acenocoumarol—Nausea—Carmustine—hematologic cancer	0.000101	0.000543	CcSEcCtD
Acenocoumarol—Vomiting—Irinotecan—hematologic cancer	0.0001	0.00054	CcSEcCtD
Acenocoumarol—Vomiting—Mitoxantrone—hematologic cancer	0.0001	0.00054	CcSEcCtD
Acenocoumarol—Nausea—Alitretinoin—hematologic cancer	9.97e-05	0.000538	CcSEcCtD
Acenocoumarol—Dermatitis—Irinotecan—hematologic cancer	9.92e-05	0.000535	CcSEcCtD
Acenocoumarol—Dermatitis—Mitoxantrone—hematologic cancer	9.92e-05	0.000535	CcSEcCtD
Acenocoumarol—Nausea—Ifosfamide—hematologic cancer	9.85e-05	0.000531	CcSEcCtD
Acenocoumarol—Nitrazepam—ABCB1—hematologic cancer	9.81e-05	0.0342	CrCbGaD
Acenocoumarol—Diarrhoea—Cisplatin—hematologic cancer	9.79e-05	0.000528	CcSEcCtD
Acenocoumarol—Alopecia—Methotrexate—hematologic cancer	9.76e-05	0.000526	CcSEcCtD
Acenocoumarol—Vomiting—Gemcitabine—hematologic cancer	9.76e-05	0.000526	CcSEcCtD
Acenocoumarol—Dermatitis—Gemcitabine—hematologic cancer	9.67e-05	0.000521	CcSEcCtD
Acenocoumarol—Hypersensitivity—Etoposide—hematologic cancer	9.65e-05	0.000521	CcSEcCtD
Acenocoumarol—Haemoglobin—Doxorubicin—hematologic cancer	9.61e-05	0.000518	CcSEcCtD
Acenocoumarol—Nausea—Vincristine—hematologic cancer	9.61e-05	0.000518	CcSEcCtD
Acenocoumarol—Haemorrhage—Doxorubicin—hematologic cancer	9.57e-05	0.000516	CcSEcCtD
Acenocoumarol—Hypersensitivity—Prednisolone—hematologic cancer	9.52e-05	0.000513	CcSEcCtD
Acenocoumarol—Urticaria—Triamcinolone—hematologic cancer	9.44e-05	0.000509	CcSEcCtD
Acenocoumarol—Body temperature increased—Triamcinolone—hematologic cancer	9.4e-05	0.000507	CcSEcCtD
Acenocoumarol—Decreased appetite—Betamethasone—hematologic cancer	9.37e-05	0.000506	CcSEcCtD
Acenocoumarol—Decreased appetite—Dexamethasone—hematologic cancer	9.37e-05	0.000506	CcSEcCtD
Acenocoumarol—Nausea—Mitoxantrone—hematologic cancer	9.36e-05	0.000505	CcSEcCtD
Acenocoumarol—Nausea—Irinotecan—hematologic cancer	9.36e-05	0.000505	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Dexamethasone—hematologic cancer	9.31e-05	0.000502	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Betamethasone—hematologic cancer	9.31e-05	0.000502	CcSEcCtD
Acenocoumarol—Alopecia—Epirubicin—hematologic cancer	9.14e-05	0.000493	CcSEcCtD
Acenocoumarol—Nausea—Gemcitabine—hematologic cancer	9.11e-05	0.000492	CcSEcCtD
Acenocoumarol—Vomiting—Cisplatin—hematologic cancer	9.09e-05	0.00049	CcSEcCtD
Acenocoumarol—Dermatitis—Cisplatin—hematologic cancer	9.01e-05	0.000486	CcSEcCtD
Acenocoumarol—Diarrhoea—Etoposide—hematologic cancer	8.97e-05	0.000483	CcSEcCtD
Acenocoumarol—Hypersensitivity—Triamcinolone—hematologic cancer	8.76e-05	0.000472	CcSEcCtD
Acenocoumarol—Urticaria—Betamethasone—hematologic cancer	8.57e-05	0.000462	CcSEcCtD
Acenocoumarol—Urticaria—Dexamethasone—hematologic cancer	8.57e-05	0.000462	CcSEcCtD
Acenocoumarol—Body temperature increased—Betamethasone—hematologic cancer	8.52e-05	0.00046	CcSEcCtD
Acenocoumarol—Body temperature increased—Dexamethasone—hematologic cancer	8.52e-05	0.00046	CcSEcCtD
Acenocoumarol—Nausea—Cisplatin—hematologic cancer	8.5e-05	0.000458	CcSEcCtD
Acenocoumarol—Alopecia—Doxorubicin—hematologic cancer	8.45e-05	0.000456	CcSEcCtD
Acenocoumarol—Vomiting—Etoposide—hematologic cancer	8.33e-05	0.000449	CcSEcCtD
Acenocoumarol—Dermatitis—Etoposide—hematologic cancer	8.25e-05	0.000445	CcSEcCtD
Acenocoumarol—Decreased appetite—Prednisone—hematologic cancer	8.16e-05	0.00044	CcSEcCtD
Acenocoumarol—Dermatitis—Prednisolone—hematologic cancer	8.14e-05	0.000439	CcSEcCtD
Acenocoumarol—Nausea—Etoposide—hematologic cancer	7.78e-05	0.00042	CcSEcCtD
Acenocoumarol—Nausea—Prednisolone—hematologic cancer	7.68e-05	0.000414	CcSEcCtD
Acenocoumarol—Vomiting—Triamcinolone—hematologic cancer	7.56e-05	0.000408	CcSEcCtD
Acenocoumarol—Dermatitis—Triamcinolone—hematologic cancer	7.49e-05	0.000404	CcSEcCtD
Acenocoumarol—Urticaria—Prednisone—hematologic cancer	7.46e-05	0.000402	CcSEcCtD
Acenocoumarol—Body temperature increased—Prednisone—hematologic cancer	7.42e-05	0.0004	CcSEcCtD
Acenocoumarol—Diarrhoea—Betamethasone—hematologic cancer	7.38e-05	0.000398	CcSEcCtD
Acenocoumarol—Diarrhoea—Dexamethasone—hematologic cancer	7.38e-05	0.000398	CcSEcCtD
Acenocoumarol—Nausea—Triamcinolone—hematologic cancer	7.06e-05	0.000381	CcSEcCtD
Acenocoumarol—Hypersensitivity—Prednisone—hematologic cancer	6.92e-05	0.000373	CcSEcCtD
Acenocoumarol—Vomiting—Betamethasone—hematologic cancer	6.86e-05	0.00037	CcSEcCtD
Acenocoumarol—Vomiting—Dexamethasone—hematologic cancer	6.86e-05	0.00037	CcSEcCtD
Acenocoumarol—Decreased appetite—Methotrexate—hematologic cancer	6.82e-05	0.000368	CcSEcCtD
Acenocoumarol—Dermatitis—Dexamethasone—hematologic cancer	6.79e-05	0.000366	CcSEcCtD
Acenocoumarol—Dermatitis—Betamethasone—hematologic cancer	6.79e-05	0.000366	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Methotrexate—hematologic cancer	6.78e-05	0.000365	CcSEcCtD
Acenocoumarol—Diarrhoea—Prednisone—hematologic cancer	6.43e-05	0.000347	CcSEcCtD
Acenocoumarol—Nausea—Dexamethasone—hematologic cancer	6.41e-05	0.000345	CcSEcCtD
Acenocoumarol—Nausea—Betamethasone—hematologic cancer	6.41e-05	0.000345	CcSEcCtD
Acenocoumarol—Decreased appetite—Epirubicin—hematologic cancer	6.38e-05	0.000344	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Epirubicin—hematologic cancer	6.34e-05	0.000342	CcSEcCtD
Acenocoumarol—Urticaria—Methotrexate—hematologic cancer	6.23e-05	0.000336	CcSEcCtD
Acenocoumarol—Body temperature increased—Methotrexate—hematologic cancer	6.2e-05	0.000335	CcSEcCtD
Acenocoumarol—Vomiting—Prednisone—hematologic cancer	5.97e-05	0.000322	CcSEcCtD
Acenocoumarol—Dermatitis—Prednisone—hematologic cancer	5.92e-05	0.000319	CcSEcCtD
Acenocoumarol—Decreased appetite—Doxorubicin—hematologic cancer	5.91e-05	0.000319	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Doxorubicin—hematologic cancer	5.87e-05	0.000316	CcSEcCtD
Acenocoumarol—Urticaria—Epirubicin—hematologic cancer	5.83e-05	0.000315	CcSEcCtD
Acenocoumarol—Body temperature increased—Epirubicin—hematologic cancer	5.81e-05	0.000313	CcSEcCtD
Acenocoumarol—Hypersensitivity—Methotrexate—hematologic cancer	5.78e-05	0.000312	CcSEcCtD
Acenocoumarol—Nausea—Prednisone—hematologic cancer	5.58e-05	0.000301	CcSEcCtD
Acenocoumarol—Hypersensitivity—Epirubicin—hematologic cancer	5.41e-05	0.000292	CcSEcCtD
Acenocoumarol—Urticaria—Doxorubicin—hematologic cancer	5.4e-05	0.000291	CcSEcCtD
Acenocoumarol—Body temperature increased—Doxorubicin—hematologic cancer	5.37e-05	0.00029	CcSEcCtD
Acenocoumarol—Diarrhoea—Methotrexate—hematologic cancer	5.37e-05	0.00029	CcSEcCtD
Acenocoumarol—Diarrhoea—Epirubicin—hematologic cancer	5.03e-05	0.000271	CcSEcCtD
Acenocoumarol—Hypersensitivity—Doxorubicin—hematologic cancer	5.01e-05	0.00027	CcSEcCtD
Acenocoumarol—Vomiting—Methotrexate—hematologic cancer	4.99e-05	0.000269	CcSEcCtD
Acenocoumarol—Dermatitis—Methotrexate—hematologic cancer	4.94e-05	0.000267	CcSEcCtD
Acenocoumarol—Vomiting—Epirubicin—hematologic cancer	4.67e-05	0.000252	CcSEcCtD
Acenocoumarol—Nausea—Methotrexate—hematologic cancer	4.66e-05	0.000251	CcSEcCtD
Acenocoumarol—Diarrhoea—Doxorubicin—hematologic cancer	4.65e-05	0.000251	CcSEcCtD
Acenocoumarol—Dermatitis—Epirubicin—hematologic cancer	4.63e-05	0.00025	CcSEcCtD
Acenocoumarol—Nausea—Epirubicin—hematologic cancer	4.36e-05	0.000235	CcSEcCtD
Acenocoumarol—Vomiting—Doxorubicin—hematologic cancer	4.32e-05	0.000233	CcSEcCtD
Acenocoumarol—Dermatitis—Doxorubicin—hematologic cancer	4.28e-05	0.000231	CcSEcCtD
Acenocoumarol—Nausea—Doxorubicin—hematologic cancer	4.04e-05	0.000218	CcSEcCtD
Acenocoumarol—CYP1A2—Metabolism—FHL2—hematologic cancer	7.52e-06	0.000224	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ACP5—hematologic cancer	7.48e-06	0.000223	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CA9—hematologic cancer	7.48e-06	0.000223	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—SPHK1—hematologic cancer	7.47e-06	0.000223	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—NCOR2—hematologic cancer	7.39e-06	0.00022	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—AGRN—hematologic cancer	7.38e-06	0.00022	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PC—hematologic cancer	7.37e-06	0.00022	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—NUP98—hematologic cancer	7.34e-06	0.000219	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—UGT1A1—hematologic cancer	7.17e-06	0.000214	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—CREBBP—hematologic cancer	7.13e-06	0.000213	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ADCY7—hematologic cancer	7.12e-06	0.000213	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—NCOA3—hematologic cancer	7.12e-06	0.000213	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GBA—hematologic cancer	7.12e-06	0.000213	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—SLC35B2—hematologic cancer	7.12e-06	0.000213	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—NUP214—hematologic cancer	7.07e-06	0.000211	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—IDH1—hematologic cancer	7.04e-06	0.00021	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7e-06	0.000209	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—HMMR—hematologic cancer	6.99e-06	0.000209	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—IDH2—hematologic cancer	6.99e-06	0.000209	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CRABP1—hematologic cancer	6.98e-06	0.000208	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—SLC22A1—hematologic cancer	6.98e-06	0.000208	CbGpPWpGaD
Acenocoumarol—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	6.97e-06	0.000208	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GSTO1—hematologic cancer	6.96e-06	0.000208	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ABCC3—hematologic cancer	6.96e-06	0.000208	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—TXN—hematologic cancer	6.96e-06	0.000208	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—MTR—hematologic cancer	6.93e-06	0.000207	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ABCG2—hematologic cancer	6.93e-06	0.000207	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—SPHK1—hematologic cancer	6.81e-06	0.000203	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ALOX5—hematologic cancer	6.8e-06	0.000203	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ENO2—hematologic cancer	6.79e-06	0.000203	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—PIK3CD—hematologic cancer	6.76e-06	0.000202	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	6.59e-06	0.000197	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GSTT1—hematologic cancer	6.59e-06	0.000197	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—NUP98—hematologic cancer	6.59e-06	0.000197	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ARNTL—hematologic cancer	6.57e-06	0.000196	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—UGT1A1—hematologic cancer	6.54e-06	0.000195	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—MTAP—hematologic cancer	6.51e-06	0.000194	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.49e-06	0.000194	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—SDC1—hematologic cancer	6.44e-06	0.000192	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ACP5—hematologic cancer	6.39e-06	0.000191	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CA9—hematologic cancer	6.39e-06	0.000191	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ADCY7—hematologic cancer	6.39e-06	0.000191	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—NCOA3—hematologic cancer	6.39e-06	0.000191	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—PIK3R1—hematologic cancer	6.38e-06	0.00019	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CRABP1—hematologic cancer	6.36e-06	0.00019	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—SLC22A1—hematologic cancer	6.36e-06	0.00019	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—NUP214—hematologic cancer	6.35e-06	0.00019	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—NCOR2—hematologic cancer	6.31e-06	0.000188	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.28e-06	0.000188	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ABCG2—hematologic cancer	6.22e-06	0.000186	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—MTR—hematologic cancer	6.22e-06	0.000186	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—JAK2—hematologic cancer	6.2e-06	0.000185	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ALOX5—hematologic cancer	6.2e-06	0.000185	CbGpPWpGaD
Acenocoumarol—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	6.17e-06	0.000184	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.15e-06	0.000184	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ENO2—hematologic cancer	6.1e-06	0.000182	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—IDH1—hematologic cancer	6.01e-06	0.000179	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—NUP98—hematologic cancer	6.01e-06	0.000179	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ABCC3—hematologic cancer	5.94e-06	0.000177	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—TXN—hematologic cancer	5.94e-06	0.000177	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GSTO1—hematologic cancer	5.94e-06	0.000177	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GSTT1—hematologic cancer	5.92e-06	0.000177	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—PIK3CB—hematologic cancer	5.89e-06	0.000176	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ADCY7—hematologic cancer	5.83e-06	0.000174	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—NCOA3—hematologic cancer	5.83e-06	0.000174	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.83e-06	0.000174	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—SPHK1—hematologic cancer	5.82e-06	0.000174	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.81e-06	0.000173	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—FHL2—hematologic cancer	5.8e-06	0.000173	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—NUP214—hematologic cancer	5.79e-06	0.000173	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—SDC1—hematologic cancer	5.78e-06	0.000173	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.73e-06	0.000171	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—AGRN—hematologic cancer	5.69e-06	0.00017	CbGpPWpGaD
Acenocoumarol—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	5.69e-06	0.00017	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ABCG2—hematologic cancer	5.67e-06	0.000169	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—MTR—hematologic cancer	5.67e-06	0.000169	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—UGT1A1—hematologic cancer	5.59e-06	0.000167	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ENO2—hematologic cancer	5.56e-06	0.000166	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.52e-06	0.000165	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CD44—hematologic cancer	5.48e-06	0.000163	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—NQO1—hematologic cancer	5.48e-06	0.000163	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.45e-06	0.000163	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CRABP1—hematologic cancer	5.44e-06	0.000162	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—SLC22A1—hematologic cancer	5.44e-06	0.000162	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—IL2—hematologic cancer	5.41e-06	0.000161	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—HMMR—hematologic cancer	5.4e-06	0.000161	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—IDH2—hematologic cancer	5.4e-06	0.000161	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GSTT1—hematologic cancer	5.39e-06	0.000161	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.36e-06	0.00016	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.31e-06	0.000159	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ALOX5—hematologic cancer	5.3e-06	0.000158	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—SDC1—hematologic cancer	5.27e-06	0.000157	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.22e-06	0.000156	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CYCS—hematologic cancer	5.18e-06	0.000155	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—HSP90AA1—hematologic cancer	5.15e-06	0.000154	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—NUP98—hematologic cancer	5.13e-06	0.000153	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ARNTL—hematologic cancer	5.07e-06	0.000151	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.04e-06	0.00015	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ADCY7—hematologic cancer	4.98e-06	0.000149	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—NCOA3—hematologic cancer	4.98e-06	0.000149	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.97e-06	0.000148	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—NUP214—hematologic cancer	4.95e-06	0.000148	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CA9—hematologic cancer	4.94e-06	0.000147	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ACP5—hematologic cancer	4.94e-06	0.000147	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CD44—hematologic cancer	4.92e-06	0.000147	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—NQO1—hematologic cancer	4.92e-06	0.000147	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.9e-06	0.000146	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.87e-06	0.000145	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—EP300—hematologic cancer	4.85e-06	0.000145	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ABCG2—hematologic cancer	4.85e-06	0.000145	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—MTR—hematologic cancer	4.85e-06	0.000145	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.81e-06	0.000144	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.76e-06	0.000142	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ENO2—hematologic cancer	4.75e-06	0.000142	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—SRC—hematologic cancer	4.72e-06	0.000141	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CYCS—hematologic cancer	4.65e-06	0.000139	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—IDH1—hematologic cancer	4.64e-06	0.000139	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.63e-06	0.000138	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	4.62e-06	0.000138	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GSTT1—hematologic cancer	4.61e-06	0.000138	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—VEGFA—hematologic cancer	4.6e-06	0.000137	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.59e-06	0.000137	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—TXN—hematologic cancer	4.59e-06	0.000137	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.59e-06	0.000137	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GSTP1—hematologic cancer	4.57e-06	0.000136	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—NRAS—hematologic cancer	4.54e-06	0.000136	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.54e-06	0.000135	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—SDC1—hematologic cancer	4.51e-06	0.000134	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.49e-06	0.000134	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CD44—hematologic cancer	4.48e-06	0.000134	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—NQO1—hematologic cancer	4.48e-06	0.000134	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.42e-06	0.000132	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.39e-06	0.000131	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—MAPK3—hematologic cancer	4.35e-06	0.00013	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ABCB1—hematologic cancer	4.32e-06	0.000129	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.31e-06	0.000129	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.3e-06	0.000128	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.25e-06	0.000127	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CYCS—hematologic cancer	4.24e-06	0.000127	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—TGFB1—hematologic cancer	4.22e-06	0.000126	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	4.21e-06	0.000126	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—NCOR1—hematologic cancer	4.2e-06	0.000125	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GSTM1—hematologic cancer	4.2e-06	0.000125	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.2e-06	0.000125	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.2e-06	0.000125	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.16e-06	0.000124	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GSTP1—hematologic cancer	4.1e-06	0.000122	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.09e-06	0.000122	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.06e-06	0.000121	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.97e-06	0.000118	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—NUP98—hematologic cancer	3.96e-06	0.000118	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—KRAS—hematologic cancer	3.91e-06	0.000117	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ABCB1—hematologic cancer	3.88e-06	0.000116	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.84e-06	0.000115	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.84e-06	0.000115	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CD44—hematologic cancer	3.83e-06	0.000114	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—NQO1—hematologic cancer	3.83e-06	0.000114	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—NUP214—hematologic cancer	3.82e-06	0.000114	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.79e-06	0.000113	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GSTM1—hematologic cancer	3.77e-06	0.000112	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—NCOR1—hematologic cancer	3.77e-06	0.000112	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.75e-06	0.000112	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—MTR—hematologic cancer	3.74e-06	0.000112	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.74e-06	0.000112	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GSTP1—hematologic cancer	3.74e-06	0.000112	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—MTHFR—hematologic cancer	3.71e-06	0.000111	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ENO2—hematologic cancer	3.67e-06	0.000109	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CYCS—hematologic cancer	3.62e-06	0.000108	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.62e-06	0.000108	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	3.6e-06	0.000108	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—PIK3CA—hematologic cancer	3.59e-06	0.000107	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.56e-06	0.000106	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ABCB1—hematologic cancer	3.54e-06	0.000106	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—SDC1—hematologic cancer	3.48e-06	0.000104	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—TP53—hematologic cancer	3.47e-06	0.000104	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GSTM1—hematologic cancer	3.44e-06	0.000103	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—NCOR1—hematologic cancer	3.44e-06	0.000103	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—MTHFR—hematologic cancer	3.33e-06	9.94e-05	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—HRAS—hematologic cancer	3.32e-06	9.92e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.27e-06	9.76e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.24e-06	9.68e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GSTP1—hematologic cancer	3.2e-06	9.54e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PIK3CG—hematologic cancer	3.12e-06	9.3e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.09e-06	9.23e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—MTHFR—hematologic cancer	3.04e-06	9.06e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ABCB1—hematologic cancer	3.02e-06	9.03e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CD44—hematologic cancer	2.96e-06	8.82e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—NQO1—hematologic cancer	2.96e-06	8.82e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.94e-06	8.76e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.94e-06	8.76e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.93e-06	8.76e-05	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—AKT1—hematologic cancer	2.93e-06	8.76e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CREBBP—hematologic cancer	2.89e-06	8.63e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.8e-06	8.35e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CYCS—hematologic cancer	2.8e-06	8.35e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.78e-06	8.3e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PIK3CD—hematologic cancer	2.74e-06	8.18e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.68e-06	7.99e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.59e-06	7.75e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.59e-06	7.74e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PIK3R1—hematologic cancer	2.59e-06	7.72e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.55e-06	7.62e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.47e-06	7.36e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.46e-06	7.34e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ALB—hematologic cancer	2.43e-06	7.25e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PIK3CB—hematologic cancer	2.39e-06	7.13e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.37e-06	7.06e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.33e-06	6.97e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.32e-06	6.93e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.29e-06	6.83e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.27e-06	6.76e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.27e-06	6.76e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.24e-06	6.69e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ALB—hematologic cancer	2.21e-06	6.61e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.18e-06	6.51e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PIK3CB—hematologic cancer	2.14e-06	6.4e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.12e-06	6.32e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PTEN—hematologic cancer	2.06e-06	6.16e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.02e-06	6.03e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—MTHFR—hematologic cancer	2e-06	5.98e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—EP300—hematologic cancer	1.97e-06	5.87e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.95e-06	5.84e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.92e-06	5.72e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ALB—hematologic cancer	1.89e-06	5.65e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PTEN—hematologic cancer	1.85e-06	5.53e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.81e-06	5.4e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—EP300—hematologic cancer	1.77e-06	5.27e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PTEN—hematologic cancer	1.69e-06	5.04e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.68e-06	5.02e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.67e-06	4.99e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—EP300—hematologic cancer	1.61e-06	4.81e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.56e-06	4.66e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.48e-06	4.42e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ALB—hematologic cancer	1.46e-06	4.36e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PIK3CA—hematologic cancer	1.46e-06	4.35e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PTEN—hematologic cancer	1.44e-06	4.31e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.4e-06	4.17e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—EP300—hematologic cancer	1.38e-06	4.11e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.31e-06	3.9e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.29e-06	3.85e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.19e-06	3.56e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—AKT1—hematologic cancer	1.19e-06	3.55e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PTEN—hematologic cancer	1.11e-06	3.33e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—AKT1—hematologic cancer	1.07e-06	3.19e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—EP300—hematologic cancer	1.06e-06	3.17e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.02e-06	3.04e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—AKT1—hematologic cancer	9.74e-07	2.91e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—AKT1—hematologic cancer	8.32e-07	2.48e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PIK3CA—hematologic cancer	7.86e-07	2.35e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—AKT1—hematologic cancer	6.42e-07	1.92e-05	CbGpPWpGaD
